Cargando…
Rhythm Control in Heart Failure Patients with Atrial Fibrillation
AF and heart failure (HF) commonly coexist. Left atrial ablation is an effective treatment to maintain sinus rhythm (SR) in patients with AF. Recent evidence suggests that the use of ablation for AF in patients with HF is associated with an improved left ventricular ejection fraction and lower death...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675141/ https://www.ncbi.nlm.nih.gov/pubmed/33240512 http://dx.doi.org/10.15420/aer.2020.23 |
_version_ | 1783611648461766656 |
---|---|
author | Eysenck, William Saba, Magdi |
author_facet | Eysenck, William Saba, Magdi |
author_sort | Eysenck, William |
collection | PubMed |
description | AF and heart failure (HF) commonly coexist. Left atrial ablation is an effective treatment to maintain sinus rhythm (SR) in patients with AF. Recent evidence suggests that the use of ablation for AF in patients with HF is associated with an improved left ventricular ejection fraction and lower death and HF hospitalisation rates. We performed a systematic search of world literature to analyse the association in more detail and to assess the utility of AF ablation as a non-pharmacological tool in the treatment of patients with concomitant HF. |
format | Online Article Text |
id | pubmed-7675141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-76751412020-11-24 Rhythm Control in Heart Failure Patients with Atrial Fibrillation Eysenck, William Saba, Magdi Arrhythm Electrophysiol Rev Clinical Arrhythmias AF and heart failure (HF) commonly coexist. Left atrial ablation is an effective treatment to maintain sinus rhythm (SR) in patients with AF. Recent evidence suggests that the use of ablation for AF in patients with HF is associated with an improved left ventricular ejection fraction and lower death and HF hospitalisation rates. We performed a systematic search of world literature to analyse the association in more detail and to assess the utility of AF ablation as a non-pharmacological tool in the treatment of patients with concomitant HF. Radcliffe Cardiology 2020-11 /pmc/articles/PMC7675141/ /pubmed/33240512 http://dx.doi.org/10.15420/aer.2020.23 Text en Copyright © 2020, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Clinical Arrhythmias Eysenck, William Saba, Magdi Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title | Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title_full | Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title_fullStr | Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title_full_unstemmed | Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title_short | Rhythm Control in Heart Failure Patients with Atrial Fibrillation |
title_sort | rhythm control in heart failure patients with atrial fibrillation |
topic | Clinical Arrhythmias |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675141/ https://www.ncbi.nlm.nih.gov/pubmed/33240512 http://dx.doi.org/10.15420/aer.2020.23 |
work_keys_str_mv | AT eysenckwilliam rhythmcontrolinheartfailurepatientswithatrialfibrillation AT sabamagdi rhythmcontrolinheartfailurepatientswithatrialfibrillation |